Ankylosing in Medical Technology
Navigation Links
Ankylosing in Medical Technology
... psoriatic arthritis (PsA) and severe, active ankylosing spondylitis (AS).
Upon Commission approval ... of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in the European Union," said Jerome ... the peak of their productive years.
About ankylosing Spondylitis ...
... in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Investigators reported these ... at two years. Improvements in the Assessment in ankylosing Spondylitis criteria (ASAS 20) were maintained ... living with the chronic inflammatory disease, ankylosing spondylitis," said Jurgen Braun, MD, lead ...
... for the treatment of RA, psoriatic arthritis and ankylosing spondylitis. In the study, GOlimumab FOR ... for adults with RA, psoriatic arthritis and ankylosing spondylitis. The initial submission and Phase ... for the treatment of RA, psoriatic arthritis and ankylosing spondylitis, golimumab is being studied as an ...
... improvements in the signs and symptoms of active ankylosing spondylitis, according to Phase 3 study results ... through six months as measured by the Bath ankylosing Spondylitis Functional Index (BASFI). Golimumab, ... ASAS 40, defined as 40 percent improvement in ankylosing spondylitis signs and symptoms, compared with ...
... patients with polyarticular symmetrical subtypes of the disease. ankylosing spondylitis Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy. ...
... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis or plaque psoriasis for a long time, ... innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's ...
... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis or plaque psoriasis for a long time, ... innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's ...
... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis for a long time, ... innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's ...
... to severe rheumatoid arthritis in 2002, psoriatic arthritis in 2005, ankylosing spondylitis in 2006, and moderate to severe Crohn's disease in 2007. ... considered before initiating therapy. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis, Crohn's disease and plaque psoriasis, ...
... is also approved for reducing signs and symptoms in patients with active ankylosing spondylitis. Earlier this year, HUMIRA was approved for reducing the ... considered before initiating therapy. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis and Crohn's disease, the safety profile ...
... arthritis in adults, in combination with methotrexate; active psoriatic arthritis in adults, alone or in combination with methotrexate; and active ankylosing spondylitis in adults. Indications in Canada: In Canada, SIMPONI, in combination with methotrexate (MTX), is indicated for reducing the ...
... rheumatology and dermatology. REMICADE has demonstrated broad clinical utility with indications in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and efficacy ...
... HUMIRA is the only fully human monoclonal antibody approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriasis, ankylosing spondylitis (AS), Crohn's disease and juvenile idiopathic arthritis (JIA) in the United States and Europe. HUMIRA resembles antibodies normally found ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
... percent vs. 9 percent). Discontinuations due to adverse events were 7 percent for HUMIRA and 4 percent for placebo. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis, Crohn's disease and plaque psoriasis, the safety profile for adult patients treated with HUMIRA was similar to the ...
... owned subsidiary of Amgen, manufactures ENBREL, which may be used to treat rheumatoid arthritis, junior rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis. Additional information about ENBREL, including the full U.S. Prescribing Information, can be found on the Web site ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
... therapy. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis and Crohn's ... arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS, an arthritis of the spine) ... signs and symptoms in patients with active ankylosing spondylitis. HUMIRA is also indicated ...
... from 279 patients with AS as part of the ankylosing Spondylitis Study for the Evaluation ... placebo-controlled study utilized the Bath ankylosing Spondylitis Metrology Index (BASMI) and chest ... see "Important Safety Information" below. About ankylosing Spondylitis AS is a painful and progressive ...
... broad clinical utility in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), ... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis for a long ...
... is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. -- ENBREL is indicated for the treatment of adult patients ... called TNF. People with an immune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, have too much TNF in ...
... and in a number of over-the-counter medications. Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. It is also indicated for the treatment of tendinitis, bursitis, acute gout and for the management of pain and ...
... About HUMIRA HUMIRA is the only fully human monoclonal antibody approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS, an arthritis of the spine) and Crohn's disease in the U.S. and Europe. HUMIRA resembles antibodies normally found in the body. It ...
... in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Investigators reported these ... at two years. Improvements in the Assessment in ankylosing Spondylitis criteria (ASAS 20) were maintained ... living with the chronic inflammatory disease, ankylosing spondylitis," said Jurgen Braun, MD, lead ...
... for the treatment of RA, psoriatic arthritis and ankylosing spondylitis. In the study, GOlimumab FOR ... for adults with RA, psoriatic arthritis and ankylosing spondylitis. The initial submission and Phase ... for the treatment of RA, psoriatic arthritis and ankylosing spondylitis, golimumab is being studied as an ...
... improvements in the signs and symptoms of active ankylosing spondylitis, according to Phase 3 study results ... through six months as measured by the Bath ankylosing Spondylitis Functional Index (BASFI). Golimumab, ... ASAS 40, defined as 40 percent improvement in ankylosing spondylitis signs and symptoms, compared with ...
... patients with polyarticular symmetrical subtypes of the disease. ankylosing spondylitis Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy. ...
... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis or plaque psoriasis for a long time, ... innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's ...
... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis or plaque psoriasis for a long time, ... innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's ...
... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis for a long time, ... innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's ...
... to severe rheumatoid arthritis in 2002, psoriatic arthritis in 2005, ankylosing spondylitis in 2006, and moderate to severe Crohn's disease in 2007. ... considered before initiating therapy. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis, Crohn's disease and plaque psoriasis, ...
... is also approved for reducing signs and symptoms in patients with active ankylosing spondylitis. Earlier this year, HUMIRA was approved for reducing the ... considered before initiating therapy. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis and Crohn's disease, the safety profile ...
... arthritis in adults, in combination with methotrexate; active psoriatic arthritis in adults, alone or in combination with methotrexate; and active ankylosing spondylitis in adults. Indications in Canada: In Canada, SIMPONI, in combination with methotrexate (MTX), is indicated for reducing the ...
... rheumatology and dermatology. REMICADE has demonstrated broad clinical utility with indications in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and efficacy ...
Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
... (golimumab), a once-monthly subcutaneous anti-TNF agent for inflammatory and autoimmune disorders (under review in EU for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, and in Phase III for ulcerative colitis); Schering-Plough has exclusive marketing rights to golimumab outside ...... HUMIRA is the only fully human monoclonal antibody approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriasis, ankylosing spondylitis (AS), Crohn's disease and juvenile idiopathic arthritis (JIA) in the United States and Europe. HUMIRA resembles antibodies normally found ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
... percent vs. 9 percent). Discontinuations due to adverse events were 7 percent for HUMIRA and 4 percent for placebo. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis, Crohn's disease and plaque psoriasis, the safety profile for adult patients treated with HUMIRA was similar to the ...
Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...... owned subsidiary of Amgen, manufactures ENBREL, which may be used to treat rheumatoid arthritis, junior rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis. Additional information about ENBREL, including the full U.S. Prescribing Information, can be found on the Web site ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...
Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
... biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis. The world leader in monoclonal antibody production ...... therapy. In HUMIRA clinical trials for ankylosing spondylitis, psoriatic arthritis and Crohn's ... arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS, an arthritis of the spine) ... signs and symptoms in patients with active ankylosing spondylitis. HUMIRA is also indicated ...
... from 279 patients with AS as part of the ankylosing Spondylitis Study for the Evaluation ... placebo-controlled study utilized the Bath ankylosing Spondylitis Metrology Index (BASMI) and chest ... see "Important Safety Information" below. About ankylosing Spondylitis AS is a painful and progressive ...
... broad clinical utility in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), ... People who have been treated for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis for a long ...
... is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. -- ENBREL is indicated for the treatment of adult patients ... called TNF. People with an immune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, have too much TNF in ...
Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA
... and in a number of over-the-counter medications. Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. It is also indicated for the treatment of tendonitis, bursitis, acute gout and for the management of pain and ...Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
... and in a number of over-the-counter medications. Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. It is also indicated for the treatment of tendinitis, bursitis, acute gout and for the management of pain and ...... and in a number of over-the-counter medications. Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. It is also indicated for the treatment of tendinitis, bursitis, acute gout and for the management of pain and ...
Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
... and in a number of over-the-counter medications. Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. It is also indicated for the treatment of tendinitis, bursitis, acute gout and for the management of pain and ...... About HUMIRA HUMIRA is the only fully human monoclonal antibody approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS, an arthritis of the spine) and Crohn's disease in the U.S. and Europe. HUMIRA resembles antibodies normally found in the body. It ...
Other ContentstoxinstoxinstoxinstoxinstoxinstoxinstoxinstoxoplasmosistoxoplasmosistransplantationtransplantationtransplantationtransplantationtransplantationtracheitistraumatraumatraumatraumatraumatraumatractiontractiontractiontractiontracheostomytrachomatrachomaOther TagsIlluminatedOccluderSnellenUltrasonicKeratomeSabreExcaliburplus
(Date:11/25/2009)...iversity assistant professors recently received fu...o continue research beneficial to understanding th... Christopher Blackwood, assistant professor in th...rants to support two separate research projects. ,...composer Communities and Functions from the Leaf t...
(Date:11/24/2009)... opening new doors to understanding how sounds ass...f a marine mammal or if they hear it at all. , ...ners that NASA uses to detect flaws in the space s...ng scientists to peek inside the giant head of a w...sional replicas of a whale,s hearing anatomy using...
(Date:11/24/2009)...American College of Medical Toxicology (ACMT) have...tion of the Journal of Medical Toxicology (JMT),...rch 2010. It was previously published by the Univ... Medical Toxicology , an international, peer-revie... and practice of medical toxicology. The quarterl...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Aflac Launches Soccer Its Eighth New Television Ad for 2009 55112 1Aflac Launches Soccer Its Eighth New Television Ad for 2009 55112 2Aflac Launches Soccer Its Eighth New Television Ad for 2009 55112 3Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE 28R 29 13656 1Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE 28R 29 13656 2Amylin Pharmaceuticals Board of Directors Elects Paulo F Costa Chairman of the Board 13654 1Amylin Pharmaceuticals Board of Directors Elects Paulo F Costa Chairman of the Board 13654 2(Date:11/30/2009)... House and Senate bills stack up , , MON...form bills moving through the U.S. Congress differ...dramatic reduction in the number of uninsured Amer...epresentatives earlier this month would expand cov...eparing to debate a proposal to expand coverage to...
(Date:11/30/2009)... APR Energy (APR) recently donated medi... La Esperanza during a Free General Health Campaig...eranza, Caja Municipal and Huggies. The donation w...e communities where they build, own and operate pl...s targeted at benefiting the areas surrounding APR...
(Date:11/30/2009)... How about a stocking stuffer that save...e,s Super-Reflective POP BANDS® , Pet Collars...ive, unique, and fun gifts that make a difference....vember 30, 2009 -- How would you like to give a gi...all year?, , , , ,Vedante,s super-reflective POP ...
(Date:11/30/2009)... According to Steven McConnell, DDS, te...ring flu season is a good idea, but brushing their...tually coming down with a virus. , ...o the California Dental Hygienists’ Associat...etween oral health and flu prevention because the ...
(Date:11/30/2009)... Firm uses Staten Island courtroom to r...endants were 100% responsible for client’s a...s Nexis) November 30, 2009 -- A Staten Island, N.Y... union paperhanger who was injured at a New York C...mondi v. J.T. Magen Construction Company et al (In...
Breaking Medicine News(10 mins):Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:APR Energy Donates Medicine and Medical Services to Community of La Esperanza 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 4Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 2Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 3Health News:Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu 4Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2[0] Health Reform: What's in It for You?[0] APR Energy Donates Medicine and Medical Services to Community of La Esperanza [0] Fun and Fashionable Holiday Gifts that Save Lives[0] Tips on Decreasing Susceptibility to the H1N1 Virus - Optimum Oral Hygiene Can Prevent Flu [0] Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident
IlluminatedUltramaticOccluderGrahamSnellenUltrasonicPachymetricMicropachPrismsHyfrecatorKeratomeSabreExcaliburplusLigasure
Other Tagsleaked 2conversations 2carry 2carry 3carry 4carry 5carry 6carry 7carry 8carry 9carry 10burn 2burn 3hole 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |